Ranjana Verma

Title: Ranjana Verma: Innovator in Schizophrenia Screening

Introduction

Ranjana Verma is a notable inventor based in Delhi, India. She has made significant contributions to the field of genetics, particularly in the area of mental health. Her work focuses on developing innovative methods for identifying genetic predispositions to schizophrenia.

Latest Patents

Ranjana Verma holds a patent for "Primers for screening schizophrenia and a method thereof." This invention relates to novel primers that are useful for identifying and screening non-sense mutations. Specifically, it targets the codon TGG, which codes for the amino acid tryptophan, substituted with TAG, a non-sense codon at nucleotide No. 825 in exon 2 of the synaptogyrin 1 gene located on chromosome 22q11-13. This method aids in detecting predisposition to schizophrenia in a subset of patients.

Career Highlights

Ranjana Verma is affiliated with the Council of Scientific and Industrial Research, where she continues her research and development efforts. Her work has garnered attention for its potential impact on understanding and diagnosing schizophrenia.

Collaborations

Ranjana has collaborated with esteemed colleagues such as Samir Kumar Brahmachari and Chitra Chauhan, contributing to a rich environment of scientific inquiry and innovation.

Conclusion

Ranjana Verma's contributions to the field of genetics and mental health through her innovative patent highlight her role as a leading inventor. Her work not only advances scientific knowledge but also has the potential to improve the lives of individuals affected by schizophrenia.